Metastatic renal cell carcinoma (MRCC)

Active Ingredient: Sunitinib

Indication for Sunitinib

Population group: only adults (18 years old or older)

Sunitinib is indicated for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults.

For this indication, competent medicine agencies globally authorize below treatments:

50 mg once daily

Route of admnistration

Oral

Defined daily dose

50 - 50 mg

Dosage regimen

From 50 To 50 mg once every day for 28 day(s)

Detailed description

The recommended dose of sunitinib is 50 mg taken orally once daily, for 4 consecutive weeks, followed by a 2-week rest period (Schedule 4/2) to comprise a complete cycle of 6 weeks.

Dosage considerations

It may be taken with or without food.

Active ingredient

Sunitinib

Sunitinib inhibits multiple RTKs that are implicated in tumour growth, neoangiogenesis, and metastatic progression of cancer.

Read more about Sunitinib

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.